NCT00880243View on ClinicalTrials.gov

Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML)

PHASE3CompletedINTERVENTIONAL
Enrollment

473

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

GM-CSF

"Randomization 1: GM-CSF (5micogram/Kg/d) versus no GM-CSF during induction chemotherapy and all consolidation courses.~Randomiization 2: Consolidation high dose AraC versus consolidation EMA"

All Listed Sponsors
collaborator

Hospices Civils de Lyon

OTHER

lead

Acute Leukemia French Association

OTHER

NCT00880243 - Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML) | Biotech Hunter | Biotech Hunter